Patent AnalyticsExaminers
Rankings

Company or institution

MacroGenics, Inc.

170 applicationsfiled 2007 to 2026

Allowance rate
72%
−3 pts vs the USPTO range 65% to 79%
Rejections before allowance
1.4
−0.1 vs the USPTO
Months to first action
22.1 mo
+3.5 vs the USPTO
Needed an RCE
24%
−3 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07K Peptides124 apps
A61K Medical preparations21 apps
A61P Therapeutic activity of compounds15 apps
G01N Investigating or analysing materials5 apps
C03C 3 apps
C12P 1 apps

Art units

164358 apps
164430 apps
164227 apps
164116 apps
164711 apps
OPAP11 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19619127ADAM9 ANTIBODY-DRUG CONJUGATES2026-08-27Pending00n/a
19513712B7-H3 ANTIBODY-DRUG CONJUGATES2026-02-24Pending00n/a
19547752COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF2026-02-24Pending00n/a
15687409Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15304068Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15766864Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15887802Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15476434Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15685003Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15864481Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 170 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in